Inventor · disambiguated record
Edward R. Lee
Also filed as: LEE EDWARD · LEE EDWARD R
30 granted patents·8 pending applications·1,463 citations·filing 1994–2018
98Inventor score
Files withGENZYME CORP25PLACON THERAPEUTICS INC5SIEGEL CRAIG4BLEND THERAPEUTICS1TARVEDA THERAPEUTICS INC1
Top patents by PatentIndex Score
38 records- 0196US5948767ACationic amphiphile/DNA complexesGENZYME CORP·Filed 1996·Granted Sep 7, 1999·271 cites·13 claims
- 0295US5767099ACationic amphiphiles containing amino acid or dervatized amino acid groups for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1995·Granted Jun 16, 1998·201 cites·22 claims
- 0394US5783565ACationic amphiphiles containing spermine or spermidine cationic group for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1996·Granted Jul 21, 1998·123 cites·4 claims
- 0494US5719131ACationic amphiphiles containing dialkylamine lipophilic groups for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1995·Granted Feb 17, 1998·119 cites·24 claims
- 0592US6071890AOrgan-specific targeting of cationic amphiphile/DNA complexes for gene therapyGENZYME CORP·Filed 1995·Granted Jun 6, 2000·128 cites·14 claims
- 0690US8304447B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsSIEGEL CRAIG·Filed 2008·Granted Nov 6, 2012·18 cites·20 claims
- 0789US5935936ACompositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1996·Granted Aug 10, 1999·85 cites·20 claims
- 0889US5650096ACationic amphiphiles for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1994·Granted Jul 22, 1997·92 cites·7 claims
- 0988US9556214B2Compounds, compositions, and methods for the treatment of cancersPLACON THERAPEUTICS INC·Filed 2013·Granted Jan 31, 2017·7 cites·2 claims
- 1088US8309593B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsSIEGEL CRAIG·Filed 2009·Granted Nov 13, 2012·15 cites·15 claims
- 1188US5925628ACationic amphiphiles for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1997·Granted Jul 20, 1999·66 cites·22 claims
- 1287US8940776B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsSIEGEL CRAIG·Filed 2012·Granted Jan 27, 2015·11 cites·19 claims
- 1382US9272996B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsSIEGEL CRAIG·Filed 2012·Granted Mar 1, 2016·6 cites·16 claims
- 1482US5948925ACationic amphiphiles containing linkers derived from neutral or positively charged amino acidsGENZYME CORP·Filed 1997·Granted Sep 7, 1999·49 cites·14 claims
- 1581US5939401ACationic amphiphile compositions for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1996·Granted Aug 17, 1999·37 cites·5 claims
- 1680US5840710ACationic amphiphiles containing ester or ether-linked lipophilic groups for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1995·Granted Nov 24, 1998·51 cites·36 claims
- 1779US10111853B2Compounds, compositions, and methods for the treatment of cancersPLACON THERAPEUTICS INC·Filed 2016·Granted Oct 30, 2018·1 cites·19 claims
- 1879US9745294B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2014·Granted Aug 29, 2017·3 cites·24 claims
- 1975US5910487ACationic amphiphiles and plasmids for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1995·Granted Jun 8, 1999·28 cites·7 claims
- 2074US6383814B1Cationic amphiphiles for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1999·Granted May 7, 2002·32 cites·16 claims
- 2174US5942634ACationic amphiphiles for cell transfectionsGENZYME CORP·Filed 1997·Granted Aug 24, 1999·27 cites·11 claims
- 2272US9744153B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2016·Granted Aug 29, 2017·1 cites·14 claims
- 2369US5747471ACationic amphiphiles containing steroid lipophilic groups for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1995·Granted May 5, 1998·37 cites·20 claims
- 2465US9771387B2Platinum compounds having a heterocycle ligand, nanoparticles, and uses thereofPLACON THERAPEUTICS INC·Filed 2014·Granted Sep 26, 2017·0 cites·10 claims
- 2564US10472380B2Platinum compounds having a heterocycle ligand, nanoparticles, and uses thereofPLACON THERAPEUTICS INC·Filed 2017·Granted Nov 12, 2019·0 cites·1 claims
- 2663US2019015378A1Compounds, compositions, and methods for the treatment of cancersPLACON THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2761US9480657B2Cabazitaxel-platinum nanoparticles and methods of using sameTARVEDA THERAPEUTICS INC·Filed 2014·Granted Nov 1, 2016·0 cites·13 claims
- 2860US5912239AImidazole-containing cationic amphiphiles for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1997·Granted Jun 15, 1999·22 cites·6 claims
- 2957US2018093981A12-Acylaminopropoanol-Type Glucosylceramide Synthase InhibitorsGENZYME CORP·Filed 2017·Application pending·0 cites
- 3056US5952516ACationic amphiphiles containing multiplesteroid lipophilic groupsGENZYME CORP·Filed 1997·Granted Sep 14, 1999·12 cites·10 claims
- 3155US6331524B1Organ-specific targeting of cationic amphiphile / DNA complexes for gene therapyGENZYME CORP·Filed 1997·Granted Dec 18, 2001·11 cites·4 claims
- 3255US2010234309A1Dendrimer CompositionsGENZYME CORP·Filed 2007·Application pending·0 cites
- 3354US2015094379A1Dendrimer CompositionsGENZYME CORP·Filed 2014·Application pending·0 cites
- 3452US2003143266A1Cationic amphiphile micellar complexesGENZYME CORP·Filed 2002·Application pending·0 cites
- 3548US6323191B1Small molecule chloride transportGENZYME CORP·Filed 1999·Granted Nov 27, 2001·10 cites·15 claims
- 3640US2014088066A1Platinum compounds, compositions and methods for the treatment of cancerBLEND THERAPEUTICS·Filed 2013·Application pending·0 cites
- 3730US2002013282A1Cationic amphipile compositions for interacelluar delivery of therapeutic moleculesFiled 1998·Application pending·0 cites
- 3827US2001048940A1Cationic amphiphile micellar complexesFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Edward R. Lee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →